Larvol Delta - CervoMed-Announces-Selection-of-Formulation-and-Dosing-Regimen-for-Planned-Phase-3-Trial-in-Patients-with-Dementia-with-Lewy-Bodies

neflamapimod (VX-745) - CervoMed

https://finance.yahoo.com/news/cervomed-announces-selection-formulation-dosing-123000677.html

Mar 4, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next